Josh Kohn-Lindquist is a contributor for The Motley Fool and Yahoo Finance. He specializes in writing about dividend stocks, long-term investing, and finding undervalued companies with potential for growth. His articles provide insights and recommendations for investors looking to make informed decisions in the stock market.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Josh Kohn-Lindquist focuses on investment analysis, particularly in the stock market. His articles often highlight specific stocks with potential for long-term growth or are trading at discounted valuations.
Given his coverage attributes, Josh may be receptive to pitches that provide data-driven insights into stock performance and valuation, as well as expert commentary from financial analysts or professionals who can offer unique perspectives on long-term investing strategies and opportunities within the S&P 500 and other relevant markets.
Since he does not have a specified geographic focus, sources with an international perspective could also appeal to him if they bring valuable insights into global market trends or companies.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Kinsale's third-quarter earnings look excellent, but management is trying to rein in expectations.
Key Points Waste Management beat analysts' expectations on both the top and bottom lines in the third quarter. However, its rising cash from operations looks even more impressive. With its sustainability investments set to pay dividends, Waste Management could see higher free cash flows over the next few years. Motley Fool Issues Rare “All In” Buy Alert
Key Points Paycom beat analysts' expectations in the third quarter and raised guidance for the rest of 2024. Perhaps more importantly, the company's automated offerings continue to gain traction. Recording its best-ever sales quarter in September, Paycom's return to double-digit growth could have some legs. Motley Fool Issues Rare “All In” Buy Alert
Tennant's future remains bright, even if the market was less than pleased with the company's third-quarter results.
By: Josh Kohn-Lindquist
Key Points Rollins' recession-resilient operations make the company worthy of an above-market valuation. In addition to its stability, the company offers investors a promising growth story. Despite consistently spending on acquisitions, Rollins has quadrupled its dividend since 2014. Motley Fool Issues Rare “All In” Buy Alert
By: Josh Kohn-Lindquist
TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.
By: Josh Kohn-Lindquist
Key Points Idexx Laboratories benefits from operating in the resilient pet healthcare industry. The company's razor-and-blade business model adds a degree of stability for investors. Idexx is soon to expand into oncology screening and also has a quickly growing software business.
Key Points Dutch Bros sailed past analysts' expectations during the third quarter. More importantly, it delivered positive free cash flow through the first three quarters of 2024. This breakeven cash generation means its store count expansion is becoming self-sustaining. Motley Fool Issues Rare “All In” Buy Alert
Key Points Doximity coasted past analysts' expectations for the quarter and raised its full-year guidance. Engagement among its growing base of 2 million medical professional members continued to hit new highs. Doximity's workflow solutions could become a valuable growth area alongside its lucrative newsfeed. Motley Fool Issues Rare “All In” Buy Alert
By: Josh Kohn-Lindquist
Zoetis (NYSE: ZTS) leads the global animal healthcare industry, offering medicines, vaccines, diagnostics, genetic tests, and other items for companion animals (pets) and livestock.
(833) 317-6278 
